期刊文献+

Nrf2活化下调AGEs诱导的内皮细胞活性氧水平 被引量:6

Activation of Nrf2 decreased reactive oxygen species in endothelial cells stimulated by advanced glycation end products
下载PDF
导出
摘要 目的探讨激活红系衍生的核因子2相关因子2(Nrf2)对晚期糖基化终末产物(AGEs)作用下的内皮细胞内活性氧(ROS)水平的影响。方法培养人脐静脉内皮细胞(HUVECs),通过Nrf2激动剂莱菔硫烷(SFN)激活Nrf2,观察AGEs刺激下HUVECs细胞ROS生成情况。结果 Nrf2活化可显著降低AGEs刺激后内皮细胞ROS水平(P<0.05)。结论增强Nrf2信号通路活性,能起到拮抗AGEs诱导内皮细胞氧化损伤的作用,从而为动脉粥样硬化尤其是糖尿病心血管并发症的防治提供新的思路和靶点。 Objective To investigated the role of Nrf2 activation in the generation of intracellular ROS in endothelial cells stimu- lated by AGEs. Methods Human umbilical vein endothelial cells(HUVECs) were cultured and incubated with AGEs and intracel- lular ROS was measured with 2', 7'-dichlorodihydrofluorescein diacetate(DCF DA). Sulforaphane was used to activate Nrf2. The role of Nrf2 in the generation of ROS was observed. Results Nrf2 activation inhibited the generation of intracellular ROS signifi cantly(P〈0.05). Conclusion Enhancement of Nrf2 pathway can reduce the AGEs-induced oxidative injury of endothelial cells,and indicate a potential target for the inhibition of the atherogenic signals triggered by AGEs.
出处 《重庆医学》 CAS CSCD 北大核心 2011年第33期3329-3330,3334,共3页 Chongqing medicine
基金 国家自然科学基金资助项目(81000134)
关键词 内皮细胞 活性氧 红系衍生的核因子2相关因子2 晚期糖基化终末产物 endothelial cells reactive oxygen species nuclear factor-erythroid 2-related factor 2 advanced glycation end products
  • 相关文献

参考文献15

  • 1Mueller CF, Laude K, McNally JS, et al. ATVB in focus : redox mechanisms in hlood vessels [ J ]. Arterioseler Thromb Vasc Biol, 2005,25 (2) : 274-278.
  • 2Levonen AL,Vahakangas E,Koponen JK,et al. Antioxi dant gene therapy for cardiovascular disease:current status and future perspectives [J]. Circulation, 2008, 117 (16):2142-2150.
  • 3Nguyen T, Nioi P, Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress[J]. J Biol Chem,2009,284(20) :13291-13295.
  • 4Horiuchi S, Araki N, Morino Y. Immunochemical approach to characterize advanced glycation end products of maillard reaction[J]. J Biol Chem, 1991,266 (12) : 7329-7332.
  • 5Heart Protection Study Collaborative Group. MRC/BHF heart rrotection study of antioxidant vitamin supplementation in 20536 high-risk individuals~ a randomised placebo controlled trial[J]. Lancet, 2002,360 (9326) : 23-33.
  • 6Yusuf S,Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators [J]. N Engl J Med,2000,342(3) :154 160.
  • 7Scheen AJ. Antioxidant vitamins in the prevention of car diovascular diseases. 2nd part, results of clinical trials[J] Rev Med Liege,2000,55(2) :105-109.
  • 8Jialal I,Devaraj S, Vitamin E. Supplementation and cardi ovascular events in high risk patients[J]. N Engl J Med, 2000,342(25) :1917-1918.
  • 9Meydani M. Vitamin E and prevention of heart disease in high-risk patients[J]. Nutr Rev,2000,58(9) :278-281.
  • 10Dworakowski R, Alom Ruiz SP, Shah AM. NADPH oxidase- derived reactive oxygen species in the regulation of endotheli- al phenotype[J]. Pharmacol Rep, 2008,60 (1) : 21-28.

同被引文献104

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部